vs

Side-by-side financial comparison of BioNexus Gene Lab Corp (BGLC) and Power REIT (PW). Click either name above to swap in a different company.

Power REIT is the larger business by last-quarter revenue ($506.1K vs $483.8K, roughly 1.0× BioNexus Gene Lab Corp). BioNexus Gene Lab Corp runs the higher net margin — -214.2% vs -262.1%, a 47.9% gap on every dollar of revenue. On growth, Power REIT posted the faster year-over-year revenue change (-11.2% vs -80.8%). Over the past eight quarters, Power REIT's revenue compounded faster (-2.7% CAGR vs -54.9%).

BioNexus Gene Lab Corp is a biotechnology company specializing in molecular diagnostic testing, genetic analysis, and related life science solutions. It caters to healthcare institutions, research organizations, and individual customers, with its primary operational and market focus on the Southeast Asian region.

H&R Real Estate Investment Trust is a Canadian open-ended real estate investment trust, specializing in commercial real estate, and based in Toronto, Ontario. It is the eighth largest REIT in Canada by market capitalization, following its 2021 strategic review, which included the sale of its Bow office tower and spin-off of Primaris REIT. H&R's portfolio spans 25.6 million sq.ft., 70% by value located in the United States and 49% focused on multi-residential properties, with the remainder inc...

BGLC vs PW — Head-to-Head

Bigger by revenue
PW
PW
1.0× larger
PW
$506.1K
$483.8K
BGLC
Growing faster (revenue YoY)
PW
PW
+69.7% gap
PW
-11.2%
-80.8%
BGLC
Higher net margin
BGLC
BGLC
47.9% more per $
BGLC
-214.2%
-262.1%
PW
Faster 2-yr revenue CAGR
PW
PW
Annualised
PW
-2.7%
-54.9%
BGLC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BGLC
BGLC
PW
PW
Revenue
$483.8K
$506.1K
Net Profit
$-1.0M
$-1.3M
Gross Margin
-0.8%
Operating Margin
-213.5%
Net Margin
-214.2%
-262.1%
Revenue YoY
-80.8%
-11.2%
Net Profit YoY
-197.5%
58.1%
EPS (diluted)
$-0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BGLC
BGLC
PW
PW
Q4 25
$483.8K
$506.1K
Q3 25
$2.5M
$513.1K
Q2 25
$2.3M
$506.8K
Q1 25
$2.1M
$485.8K
Q4 24
$2.5M
$569.8K
Q3 24
$2.6M
$1.4M
Q2 24
$2.0M
$519.3K
Q1 24
$2.4M
$534.6K
Net Profit
BGLC
BGLC
PW
PW
Q4 25
$-1.0M
$-1.3M
Q3 25
$-709.0K
$223.6K
Q2 25
$-616.2K
$320.9K
Q1 25
$-623.3K
$-1.4M
Q4 24
$-348.3K
$-3.2M
Q3 24
$-1.3M
$-325.0K
Q2 24
$199.1K
$-19.1M
Q1 24
$-103.8K
$-2.1M
Gross Margin
BGLC
BGLC
PW
PW
Q4 25
-0.8%
Q3 25
14.8%
Q2 25
16.3%
Q1 25
16.1%
Q4 24
12.3%
Q3 24
12.4%
Q2 24
14.6%
Q1 24
15.3%
Operating Margin
BGLC
BGLC
PW
PW
Q4 25
-213.5%
Q3 25
-27.6%
Q2 25
-27.0%
Q1 25
-28.9%
Q4 24
-16.5%
Q3 24
-50.9%
Q2 24
13.1%
Q1 24
-3.3%
Net Margin
BGLC
BGLC
PW
PW
Q4 25
-214.2%
-262.1%
Q3 25
-27.9%
43.6%
Q2 25
-27.3%
63.3%
Q1 25
-29.2%
-290.9%
Q4 24
-13.8%
-555.2%
Q3 24
-51.1%
-22.8%
Q2 24
10.1%
-3686.4%
Q1 24
-4.4%
-388.5%
EPS (diluted)
BGLC
BGLC
PW
PW
Q4 25
$-0.43
Q3 25
$-0.40
$0.02
Q2 25
$-0.34
$0.05
Q1 25
$-0.04
$-0.47
Q4 24
$0.55
$-0.98
Q3 24
$-0.75
$-0.14
Q2 24
$0.11
$-5.70
Q1 24
$-0.01
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BGLC
BGLC
PW
PW
Cash + ST InvestmentsLiquidity on hand
$2.5M
$2.2M
Total DebtLower is stronger
$20.4M
Stockholders' EquityBook value
$8.6M
$5.1M
Total Assets
$9.3M
$26.9M
Debt / EquityLower = less leverage
3.97×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BGLC
BGLC
PW
PW
Q4 25
$2.5M
$2.2M
Q3 25
$2.0M
Q2 25
$1.5M
Q1 25
$2.0M
Q4 24
$2.9M
$2.2M
Q3 24
$2.2M
Q2 24
$2.5M
Q1 24
$3.0M
Total Debt
BGLC
BGLC
PW
PW
Q4 25
$20.4M
Q3 25
$20.5M
Q2 25
$20.9M
Q1 25
$38.8M
Q4 24
$37.9M
Q3 24
$37.5M
Q2 24
$37.4M
Q1 24
$36.2M
Stockholders' Equity
BGLC
BGLC
PW
PW
Q4 25
$8.6M
$5.1M
Q3 25
$6.8M
$6.2M
Q2 25
$7.5M
$5.9M
Q1 25
$7.8M
$5.5M
Q4 24
$8.3M
$6.8M
Q3 24
$9.4M
$9.8M
Q2 24
$9.5M
$10.0M
Q1 24
$9.3M
$28.9M
Total Assets
BGLC
BGLC
PW
PW
Q4 25
$9.3M
$26.9M
Q3 25
$7.6M
$28.0M
Q2 25
$9.4M
$27.9M
Q1 25
$9.5M
$45.6M
Q4 24
$10.4M
$46.1M
Q3 24
$11.0M
$48.4M
Q2 24
$11.1M
$49.8M
Q1 24
$11.2M
$68.9M
Debt / Equity
BGLC
BGLC
PW
PW
Q4 25
3.97×
Q3 25
3.30×
Q2 25
3.51×
Q1 25
7.07×
Q4 24
5.61×
Q3 24
3.84×
Q2 24
3.76×
Q1 24
1.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BGLC
BGLC
PW
PW
Operating Cash FlowLast quarter
$961.1K
$-68.3K
Free Cash FlowOCF − Capex
$960.1K
FCF MarginFCF / Revenue
198.5%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BGLC
BGLC
PW
PW
Q4 25
$961.1K
$-68.3K
Q3 25
$-1.2M
$476.4K
Q2 25
$-737.9K
$-240.5K
Q1 25
$-824.1K
$-436.6K
Q4 24
$219.2K
$-1.4M
Q3 24
$-1.6M
$-161.8K
Q2 24
$-672.3K
$-541.5K
Q1 24
$-37.2K
$-402.2K
Free Cash Flow
BGLC
BGLC
PW
PW
Q4 25
$960.1K
Q3 25
$-1.2M
Q2 25
$-759.4K
Q1 25
$-833.1K
Q4 24
$215.2K
Q3 24
$-1.8M
Q2 24
$-674.1K
Q1 24
$-59.1K
FCF Margin
BGLC
BGLC
PW
PW
Q4 25
198.5%
Q3 25
-48.9%
Q2 25
-33.6%
Q1 25
-39.0%
Q4 24
8.5%
Q3 24
-68.5%
Q2 24
-34.1%
Q1 24
-2.5%
Capex Intensity
BGLC
BGLC
PW
PW
Q4 25
0.2%
Q3 25
0.2%
Q2 25
0.9%
Q1 25
0.4%
Q4 24
0.2%
Q3 24
7.6%
Q2 24
0.1%
Q1 24
0.9%
Cash Conversion
BGLC
BGLC
PW
PW
Q4 25
Q3 25
2.13×
Q2 25
-0.75×
Q1 25
Q4 24
Q3 24
Q2 24
-3.38×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons